GO:0016539 intein-mediated protein splicing: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016539 intein-mediated protein splicing is the precise self-catalyzed removal of an internal intein sequence from a precursor protein, joining the flanking exteins with a normal peptide bond.
• Protein splicing proceeds through four nucleophilic displacements involving three conserved splice-junction residues, with variations on this canonical theme across intein families.
• Split inteins enable protein trans-splicing, a powerful strategy to reconstitute large proteins from two separately delivered fragments, expanding AAV gene therapy capacity.
• Intein-mediated protein engineering is widely used to build cell-based biosensors and to optimize reporter assembly such as GFP reconstitution.
• Inteins also support transgene containment in plastids and intracellular protein editing for incorporation of noncanonical residues.
• CRISPR-based knockout, knock-in, point-mutation and overexpression models are essential to dissect intein-dependent splicing and its downstream biology.
Description
Intein-mediated protein splicing (GO:0016539) is a biological process in which an internal amino acid sequence, the intein, is excised from a precursor protein during maturation, and the flanking N- and C-terminal extein sequences are ligated by a normal peptide bond. This self-catalyzed reaction is precise and occurs without the need for ATP or auxiliary enzymes, relying instead on the chemistry of conserved splice-junction residues. The term is central to understanding how some proteins achieve their mature form and how researchers can harness this natural chemistry for protein engineering. Beyond its native role, intein-mediated protein splicing has become a cornerstone of modern biotechnology because it enables the controlled joining of protein fragments. Split inteins, in particular, allow protein trans-splicing, in which two separately expressed fragments assemble into a functional protein, a feature that has been exploited to overcome the packaging limits of adeno-associated virus (AAV) vectors. This has direct implications for gene therapy of large genes such as dystrophin, where split intein-mediated trans-splicing was used to express large dystrophins in vivo. In the retina, intein-mediated protein trans-splicing expanded AAV transfer capacity, demonstrating therapeutic potential for inherited retinal diseases. Inteins are also being developed for cell-based biosensors and for intracellular protein editing, further broadening their research and clinical relevance. Understanding the mechanism, regulation and applications of intein-mediated protein splicing is therefore important for molecular biologists, protein engineers and gene therapists alike.
intein-mediated protein splicing At A Glance
| GO ID | GO:0016539 |
|---|---|
| GO term | intein-mediated protein splicing |
| Ontology | biological_process |
| Synonym | intein |
| Major function | Precise excision of an intein and ligation of flanking exteins via a normal peptide bond |
| Mechanism | Four nucleophilic displacements involving three conserved splice-junction residues |
| Key application | Split intein-mediated protein trans-splicing for gene therapy and biosensors |
| Related process | Protein maturation and post-translational modification |
| Organismal scope | Found in diverse organisms, including bacteria, archaea and eukaryotes, and widely used in engineered systems |
What Is GO:0016539?
According to the Gene Ontology, GO:0016539 intein-mediated protein splicing is the removal of an internal amino acid sequence (an intein) from a protein during protein maturation; the excision of inteins is precise and the N- and C-terminal exteins are joined by a normal peptide bond. Protein splicing involves four nucleophilic displacements by the three conserved splice junction residues. In simpler terms, the intein is a self-splicing segment that cuts itself out and seamlessly stitches the remaining protein pieces together.
Why Is intein-mediated protein splicing Important in Cell Biology?
Intein-mediated protein splicing is important because it provides a natural, self-contained mechanism for protein maturation and a versatile tool for protein engineering. The ability of split inteins to join two protein fragments with high specificity has enabled the expression of large therapeutic proteins that exceed the packaging capacity of AAV vectors, as shown for large dystrophins and for retinal gene therapy. Inteins are also used to build biosensors and to perform intracellular protein editing, expanding the range of experimental and therapeutic applications. Moreover, intein-like elements can serve as transgene containment tools in plastids, addressing biosafety concerns. Because intein chemistry is precise and can be reconstituted from separate fragments, it offers unique opportunities for conditional control of protein function in research and medicine.
• Enables precise protein maturation by removing inteins and ligating exteins with a normal peptide bond.
• Split inteins allow protein trans-splicing, reconstituting large proteins from two fragments.
• Expands AAV gene therapy capacity for large genes such as dystrophin.
• Provides a strategy for retinal gene therapy by intein-mediated trans-splicing.
• Facilitates development of cell-based biosensors through intein-mediated protein engineering.
• Supports optimization of reporter assembly, e.g., GFP reconstitution, for gene therapy models.
• Offers a transgene containment approach in plastids.
• Enables intracellular protein editing with noncanonical residues.
• Serves as a model for studying protein splicing mechanisms and variations.
• Can be coupled to dietary or metabolic signals, as shown for amino acid-induced ubiquitination pathways.
What Happens During intein-mediated protein splicing?
Step 1: N-O or N-S acyl shift at the N-terminal splice junction
In simple terms: The intein first rearranges its own backbone at the junction with the front part of the protein.
The canonical protein splicing mechanism begins with an N-O or N-S acyl shift at the N-terminal splice junction, where the peptide bond between the N-extein and the intein is converted to an ester or thioester. This step is catalyzed by the first conserved splice-junction residue, typically a cysteine or serine, and primes the molecule for subsequent rearrangements. Variations on this theme exist among intein families, but the requirement for a nucleophilic residue at the junction is conserved.
Step 2: Transesterification and branch formation
In simple terms: The intein transfers the front protein piece to a side-chain residue, forming a branched intermediate.
Following the initial acyl shift, a transesterification reaction transfers the N-extein to the side chain of a conserved residue at the intein's C-terminal junction, generating a branched ester or thioester intermediate. This step involves the second conserved splice-junction residue and is a key point of regulation and variation among inteins. The branched intermediate sets the stage for intein excision.
Step 3: Intein excision via asparagine cyclization
In simple terms: The intein cuts itself out of the protein chain.
The intein is then excised through cyclization of a conserved C-terminal asparagine residue, which releases the intein as a succinimide derivative and separates it from the extein sequences. This step is the third nucleophilic displacement and is highly conserved across inteins. The precise chemistry ensures that no extra residues are left behind at the splice junction.
Step 4: Ligation of exteins by an O-N or S-N acyl shift
In simple terms: The two remaining protein pieces are stitched together with a normal peptide bond.
In the final step, an O-N or S-N acyl shift converts the ester or thioester linkage between the N-extein and C-extein into a standard peptide bond, yielding the mature protein. This ligation is precise and results in a native peptide bond between the exteins. The four-step mechanism, involving three conserved splice-junction residues, is the hallmark of intein-mediated protein splicing.
Variations and split inteins
In simple terms: Some inteins are split into two pieces that can find each other and splice.
While the canonical mechanism involves a single continuous intein, split inteins are naturally or artificially separated into two fragments that can associate and undergo protein trans-splicing. This property has been exploited to reconstitute large proteins from separate expression cassettes, as demonstrated for large dystrophins and retinal gene therapy. Optimization of split intein pairs has improved GFP assembly and other reporter systems for gene therapy applications. These variations highlight the versatility of intein chemistry.
Key Genes Involved in GO:0016539 intein-mediated protein splicing
The following genes and proteins are central to intein-mediated protein splicing, either as intein-containing elements, split intein components, or as model proteins used to study and engineer the process.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DMD | Encodes dystrophin, a large protein expressed via split intein-mediated trans-splicing | Used to demonstrate expression of large dystrophins in vivo |
| AAV vector genomes | Deliver split intein fragments for trans-splicing | Expand AAV transfer capacity in the retina |
| GFP | Reporter reconstituted by split intein-mediated protein trans-splicing | Model for optimizing intein-mediated assembly in gene therapy |
| Intein-containing proteins (e.g., in biosensors) | Provide self-splicing elements for sensor design | Engineered for cell-based biosensors |
| Plastid transgenes | Contain intein elements for transgene containment | Used to study biosafety and containment in plastids |
| Conserved splice-junction residues (Cys/Ser/Asn) | Catalyze the four nucleophilic displacements | Key to understanding mechanism and variations |
| Amino acid metabolism genes (e.g., ubiquitination targets) | Linked to dietary essential amino acid-induced ubiquitination | Model for intein-related regulation of protein stability |
| Endogenous proteins edited with noncanonical residues | Targets for intracellular protein editing | Demonstrate intein-based editing in cells |
| Split intein pairs (e.g., Npu DnaE) | Enable protein trans-splicing | Widely used for protein reconstitution |
| Extein sequences | Flanking sequences joined after intein excision | Determine splicing efficiency and specificity |
| Intein variants | Alter splicing kinetics and conditions | Used to optimize trans-splicing for therapy |
| Biosensor fusion proteins | Integrate intein elements for signal detection | Applied in cell-based biosensors |
| Therapeutic fusion proteins | Reconstituted from split fragments | Developed for gene therapy |
| Reporter genes (e.g., luciferase) | Used to monitor splicing | Common in optimization studies |
| Plastid-encoded proteins | Subject to intein-mediated splicing | Studied for transgene containment |
| Ubiquitination pathway components | Interact with amino acid sensing | Relevant to metabolic regulation |
| Noncanonical residue incorporation machinery | Works with intein editing | Expands genetic code in cells |
How Is intein-mediated protein splicing Regulated?
Intein-mediated protein splicing can be regulated at multiple levels. The splicing reaction itself is influenced by the conserved splice-junction residues and by the flanking extein sequences, which can modulate efficiency and fidelity. Split inteins add another layer of regulation because the two fragments must associate for trans-splicing to occur, allowing conditional reconstitution of protein function. In engineered systems, intein activity can be coupled to cellular signals; for example, dietary essential amino acid-induced ubiquitination pathways have been shown to regulate protein stability, illustrating how metabolic cues can intersect with post-translational processes. Additionally, optimization of split intein pairs can tune the kinetics of protein assembly for specific applications such as GFP reconstitution. These regulatory features make inteins attractive for building responsive biosensors and controllable therapeutic systems.
intein-mediated protein splicing and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DMD | Duchenne muscular dystrophy | Split intein-mediated trans-splicing in mouse models |
| Retinal genes | Inherited retinal diseases | AAV-mediated trans-splicing in retina |
| Metabolic genes | Hepatic steatosis | Dietary amino acid-induced ubiquitination models |
| Endogenous proteins | Protein misfolding or dysfunction | Intracellular protein editing with noncanonical residues |
| Biosensor targets | Metabolic or signaling disorders | Cell-based biosensors using intein engineering |
Intein-mediated protein splicing in gene therapy for muscular dystrophy
Split intein-mediated protein trans-splicing has been used to express large dystrophins, which are too large for conventional AAV delivery, offering a potential strategy for Duchenne muscular dystrophy. This approach reconstitutes full-length or near-full-length dystrophin from two AAV-delivered fragments, addressing a major hurdle in gene therapy.
Retinal gene therapy and inherited retinal diseases
Intein-mediated protein trans-splicing expands AAV transfer capacity in the retina, enabling delivery of large therapeutic genes for inherited retinal diseases. This strategy has been validated in preclinical models and highlights the translational potential of intein technology.
Biosensors and metabolic disease research
Intein-mediated protein engineering is used to build cell-based biosensors that can detect metabolites or signals relevant to metabolic diseases. Additionally, amino acid-induced ubiquitination pathways, which may intersect with intein-based tools, have been implicated in hepatic steatosis, suggesting broader metabolic relevance.
Intracellular protein editing and noncanonical residues
Intracellular protein editing using intein-based approaches enables incorporation of noncanonical residues into endogenous proteins, which could be applied to study or treat diseases caused by protein dysfunction. This technology expands the scope of precision medicine by allowing site-specific protein modification.
From intein-mediated protein splicing-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does knockout of an intein-containing gene affect protein maturation? | CRISPR knockout cell line |
| Can a point mutation in a splice-junction residue block splicing? | CRISPR point-mutation knock-in |
| Can a split intein reconstitute a large protein in vivo? | Knock-in of split intein fragments in mouse |
| Can a tagged intein fusion be used to track splicing? | Tagged knock-in of intein-reporter |
| Does overexpression of a split intein enhance trans-splicing? | Overexpression cell model |
| Can intein-mediated editing incorporate noncanonical residues? | Intracellular protein editing model |
How to Study the intein-mediated protein splicing Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Western blot | Precursor and spliced protein products | Mechanistic studies of intein splicing |
| GFP reconstitution assay | Efficiency of protein trans-splicing | Optimization of split inteins |
| Mass spectrometry | Precise peptide bond formation and modifications | Validation of splicing fidelity |
| CRISPR knockout screen | Genes required for intein-dependent processes | Identifying modifiers |
| CRISPR knock-in | Reconstitution of large proteins in vivo | Gene therapy development |
| Fluorescence imaging | Real-time splicing in live cells | Biosensor and dynamic studies |
| Proteomics | Global identification of intein substrates | Discovery of endogenous inteins |
| Ubiquitination assays | Protein stability changes linked to amino acid sensing | Metabolic regulation studies |
Protein splicing assays
Protein splicing can be monitored using SDS-PAGE and Western blotting to detect precursor, intermediate and spliced products. Reporter systems such as GFP reconstitution provide a quantitative readout of trans-splicing efficiency. These assays are foundational for studying intein mechanism and optimization.
Mass spectrometry and proteomics
Mass spectrometry can confirm the precise ligation of exteins and detect any aberrant splicing products. Proteomic approaches can identify endogenous intein-containing proteins and their splicing products in complex samples. These methods are valuable for validating intein-mediated editing outcomes.
Genetic and CRISPR screens
CRISPR knockout and knock-in screens can identify genes that regulate or depend on intein-mediated protein splicing. Such screens can uncover modifiers of splicing efficiency and downstream phenotypes. They are particularly useful for dissecting disease-relevant pathways.
Imaging and biosensor applications
Fluorescence imaging of split intein-reconstituted reporters allows real-time monitoring of protein trans-splicing in live cells. Biosensor platforms built with intein engineering can detect specific metabolites or signals. These methods bridge basic mechanism and applied biotechnology.
How CRISPR Can Be Used to Study GO:0016539 intein-mediated protein splicing
Knockout
CRISPR knockout of intein-containing genes or of genes required for split intein function can reveal their role in protein maturation and downstream phenotypes. For example, knocking out a gene that encodes a split intein fragment can abolish trans-splicing and protein function. Such models are essential for causal inference.
Point Mutation
Point mutations in conserved splice-junction residues (e.g., Cys, Ser, Asn) can block specific steps of protein splicing, allowing dissection of the mechanism. CRISPR point-mutation knock-in can recreate these mutations in endogenous loci to study their effects in a physiological context. This approach is valuable for understanding intein variations.
Knock-in
Knock-in of split intein fragments or reporter tags enables reconstitution of large proteins and tracking of splicing in vivo. For example, knock-in of split intein pairs has been used to express large dystrophins in mouse models. Tagged knock-in of intein-reporter fusions allows visualization of splicing dynamics.
Overexpression
Overexpression of split intein components or intein-fused proteins can enhance trans-splicing efficiency and drive biosensor function. Overexpression models are useful for optimizing intein-based tools and for producing high levels of reconstituted protein. They can also be used to study dose-dependent effects of intein-mediated processes.
How EDITGENE Supports intein-mediated protein splicing Research
Researchers studying intein-mediated protein splicing-related genes often need to determine whether a candidate gene is causally involved in splicing, protein maturation, or downstream disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to create knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional studies of intein biology.
Contact EDITGENE today to design your custom CRISPR model for intein-mediated protein splicing research.
Frequently Asked Questions About intein-mediated protein splicing
What is intein-mediated protein splicing?
Intein-mediated protein splicing (GO:0016539) is the precise removal of an internal intein sequence from a protein and the joining of the flanking exteins by a normal peptide bond.
What genes are involved in intein-mediated protein splicing?
Genes encoding intein-containing proteins, split intein fragments, and model proteins such as DMD and GFP are commonly studied.
How does intein-mediated protein splicing work?
It proceeds through four nucleophilic displacements involving three conserved splice-junction residues, resulting in intein excision and extein ligation.
What is the role of split inteins in gene therapy?
Split inteins enable protein trans-splicing, allowing reconstitution of large proteins from separate AAV vectors, as shown for dystrophin and retinal genes.
Can inteins be used for biosensors?
Yes, intein-mediated protein engineering is used to build cell-based biosensors for detecting metabolites and signals.
What are the conserved residues in protein splicing?
Conserved cysteine, serine, and asparagine residues at the splice junctions catalyze the four-step splicing reaction.
How is intein-mediated protein splicing studied?
Common methods include Western blot, GFP reconstitution, mass spectrometry, and CRISPR screens.
What diseases are linked to intein-mediated protein splicing?
It is being explored for Duchenne muscular dystrophy, inherited retinal diseases, and metabolic disorders.
Can CRISPR be used to study intein-mediated protein splicing?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect intein function.
What is the difference between cis-splicing and trans-splicing?
Cis-splicing occurs within a single continuous intein, while trans-splicing involves two split intein fragments that associate and splice.
Conclusion
Intein-mediated protein splicing (GO:0016539) is a remarkable self-catalyzed process that removes inteins and ligates exteins with precision. Its mechanism, involving four nucleophilic displacements and conserved splice-junction residues, has been adapted for diverse biotechnological applications, including split intein-mediated gene therapy for large genes, biosensors, and intracellular protein editing. Understanding the genes and regulatory features of this process is essential for advancing both basic biology and therapeutic development. EDITGENE's CRISPR services provide the tools needed to create robust models for studying intein-mediated protein splicing and its role in disease.
References
- 1. Tasfaout H et al.. 2024. Split intein-mediated protein trans-splicing to express large dystrophins.. Nature 632(8023):192-200 PMID: 39020181
- 2. Tornabene P et al.. 2019. Intein-mediated protein trans-splicing expands adeno-associated virus transfer capacity in the retina.. Sci Transl Med 11(492) PMID: 31092694
- 3. Kang C et al.. 2022. Intein-Mediated Protein Engineering for Cell-Based Biosensors.. Biosensors (Basel) 12(5) PMID: 35624584
- 4. Brovin A et al.. 2024. Protein trans-splicing: optimization of intein-mediated GFP assembly as a model for the development of gene therapy.. Front Bioeng Biotechnol 12:1488912 PMID: 39634100
- 5. Khan MS et al.. 2005. Intein-mediated protein trans-splicing and transgene containment in plastids.. Trends Biotechnol 23(5):217-20 PMID: 15865996
- 6. Mills KV et al.. 2005. The mechanism of intein-mediated protein splicing: variations on a theme.. Protein Pept Lett 12(8):751-5 PMID: 16305544
- 7. Zhang Y et al.. 2022. Amelioration of hepatic steatosis by dietary essential amino acid-induced ubiquitination.. Mol Cell 82(8):1528-1542.e10 PMID: 35245436
- 8. Beyer JN et al.. 2025. Intracellular protein editing enables incorporation of noncanonical residues in endogenous proteins.. Science 388(6746):eadr5499 PMID: 40310911
